Skip to content
Peptomyc Logo Peptomyc Logo Peptomyc Logo
  • ABOUT PEPTOMYC
  • Team
  • Board of Directors
  • Development Advisory Board (DAB)
  • Scientific Advisory Board (SAB)
  • Partners
  • Technology
  • MYCure Project
  • Code of Ethics and Conduct
  • NEWS
  • FOR INVESTORS
  • CONTACT
Loading...
  • News

  • Developing a Myc inhibitor to treat cancer

Peptomyc steps forward as a Clinical Stage Biotech company

21 / 12 / 20|

Peptomyc announces new equity financing round led by Aurora Science

16 / 12 / 20|

Peptomyc receives 1.293.695,64 € from Spanish Mineco and European Commission joint fund

21 / 10 / 20|

Peptomyc appoints Dr. Pepi Morales as Clinical Project Leader

20 / 10 / 20|

Peptomyc’s CEO Laura Soucek recognized as a Life Science Leader by Pharma Intelligence

09 / 06 / 20|

CEO explains her driving goal: “I want to eradicate cancer”

08 / 06 / 20|

Flurry of scientific reviews published by Peptomyc

12 / 05 / 20|

Peptomyc appoints CFO

12 / 02 / 20|

CEO Laura Soucek featured in special interview by El Mundo and IKEA

02 / 10 / 19|

Peptomyc appoints Manuela Niewel, M.D. as Chief Medical Officer

26 / 09 / 19|

Peptomyc wins funding from the SME Instrument Phase II

30 / 07 / 19|

Co-founders Laura Soucek and Marie-Eve Beaulieu featured in Nike’s promotion for the new FC Barcelona shirt

08 / 07 / 19|

Previous234Next
® Peptomyc
Centre CELLEX
C/ Natzaret, 115-117 Barcelona, Spain, 08035
Tlf. Office +34 932 543 450 (ext. 8636)
  • Privacy Policy
  • Legal notice
  • Cookies
Page load link
This website uses cookies to ensure you get the best experience on our website. More info OK